Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 289 of 640

Advanced search

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

FDA RECALL ALERT: Drugs, Medical Devices and Foods Pulled Over Serious Safety Concerns

Los Cerritos Community NewsOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

MMJ Challenges Washington's "No Product" Cannabinoid Narrative as Dr. Oz Endorses Unvalidated CMS Hemp Products

newswire.comOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (MBRX): CVI and Heights disclose 1.86M-share, 9.9% ownership

Stock TitanOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

AbCellera Stock Surges Following Positive Menopause Drug Trial

sekbernews.idOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates NRx Pharmaceuticals stock rating at buy By Investing.com

Investing.com UKOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Biotech entrepreneur Greg Verdine scores a victory after leasing big office in Watertown

The Boston GlobeOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Charlottesville biotech interns wrap up summer program with capstone presentations

WVIROriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

MHRA approves orforglipron weight-loss pill

The Pharmaceutical JournalOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Food safety concerns grow as HHS proposes new food policies

KCRAOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Stanford expands access to revolutionary pancreatic cancer drug

Stanford MedicineOriginal source

🇧🇷Aug 11Regulatoryinterfarma.org.brTier 1 · Regulatory source

Fraudes, desperdícios e sobreutilização impactam mais a sustentabilidade dos planos de saúde do que medicamentos, aponta estudo da Interfarma

Interfarma BrazilOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Judge Blocks DOD Military Label For Chinese Biotech Co.

Law360Original source

🌍Aug 11discoverynews.google.comTier 2 · Trade media

FDA to require notice of additives in food supply for the first time

STATOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Health Sector Updates: Key Highlights and Developments

DevdiscourseOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Kodiak’s Eye Trial Tests Dosing Up to Six Months Apart

Stock TitanOriginal source

🌍Aug 11discoverynews.google.comTier 2 · Trade media

Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path

Fierce PharmaOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Biotech firm Nkarta posts Q2 net loss; cash runway into 2029

TradingViewOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Belgian biotech company picks San Antonio for first U.S. operation

San Antonio Express-NewsOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Canaccord cuts CervoMed stock price target on funding uncertainty By Investing.com

Investing.com UKOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical giant to build $2.3B plant, create 500 jobs in Texas

USA TodayOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Stempoint Capital's Michelle Ross talks her biotech investing playbook

CNBCOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Purple Biotech (PPBT) highlights CAPTN-3 entry to clinic, CM24 PDAC efficacy and $44B TAM

Stock TitanOriginal source

🌍Aug 11Researchuab.eduTier 2 · Direct publisher

UAB St. Vincent’s St. Clair received $750,000 from community partners to enhance medical care

University of Alabama at BirminghamOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

RFK Jr’s food crackdown: US FDA proposes stricter food additive rules — What changes for packaged food and consumers?

livemint.comOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Opinion: The next biotech boom won’t be on a coast

Crain's Chicago BusinessOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Court sides with state over pharmaceutical companies on 2025 law

sdpb.orgOriginal source

🌍Aug 11discoverynews.google.comTier 2 · Trade media

Manufacturing problems cited in FDA rejection of ITM's radiopharma drug

Endpoints NewsOriginal source

🇺🇸Aug 11Researchnews.nm.orgTier 2 · Direct publisher

After Beating a Rare and Aggressive Cancer Twice, Retired Nurse Credits Northwestern Medicine for Helping Her Return to Life in Remission

Northwestern MedicineOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA

The Manila TimesOriginal source

🌍Aug 11Mediaskpharmteco.comTier 3 · Secondary coverage

Viral Vector Manufacturing | On-Demand OPCU July 2026

SkpharmtecoOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

Quiver QuantitativeOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Jazz Acquires Actio Bioscience | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Aug 11Researchuab.eduTier 2 · Direct publisher

Why clinical trials matter: Revolutionary new kidney treatments show what UAB can deliver for Alabama patients

University of Alabama at BirminghamOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Innovative Structures Taking China Biotech Global

kingandwood.comOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Trump officials propose new scrutiny of food additives and ingredients

The New Indian ExpressOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY

Yahoo FinanceOriginal source

🇧🇷Aug 11Regulatoryinterfarma.org.brTier 1 · Regulatory source

Baixe o estudo Saúde Suplementar em Transição: Acesso à Inovação e Valor Assistencial

Interfarma BrazilOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications

Genetic Engineering and Biotechnology NewsOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Leaders in the Loop: How Biotech Leadership Is Thinking About AI

Foley HoagOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

William Blair downgrades Tenax Therapeutics stock rating on trial results

Investing.comOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Global drugmakers invest billions to boost US presence

ReutersOriginal source

🇺🇸Aug 11Researchorbimed.comTier 2 · Direct publisher

BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering

OrbiMedOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

How EHS digitalization improves safety performance in the pharmaceutical industry

Wolters KluwerOriginal source

🇺🇰Aug 11Regulatorygov.ukTier 1 · Regulatory source

A guide to Meningococcal B vaccination for eligible young people

This guide is for teenagers and young people offered the Meningococcal B (MenB) vaccine as part of t...

UK Health Security AgencyOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Expired Food Found At Bengaluru’s Luxury Hotels In FDA Raids

Asian HospitalityOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Graph neural networks uncover pharmaceutical fraud

SiliconANGLEOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical industry loses bid to scuttle South Dakota law

The Dakota ScoutOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Major pharmaceutical company plans $2.3B Houston manufacturing campus, 500 jobs

khou.comOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

StockStoryOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Fulcrum Therapeutics stock plunges 51% after FD...

PluangOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical giant to bring $2.3B manufacturing plant, 500 jobs to Houston

Houston ChronicleOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News.

Barron'sOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Reshoring Update: BMS Commits $2.3B to Houston Campus

Pharmaceutical CommerceOriginal source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Quantum BioPharma Gets FDA Green Light for Phase 2 Trial of Lucid-MS in Multiple Sclerosis

citybuzz -Original source

🌍Aug 11discoverynews.google.comTier 3 · Aggregated media

Device firms back latest MDUFA deal, while patients want more postmarket safety

MedTech DiveOriginal source

🌍Aug 10discoverynews.google.comTier 3 · Aggregated media

Phase 3 trial begins testing potential Angelman syndrome treatment

angelmansyndromenews.comOriginal source

🌍Aug 10discoverynews.google.comTier 3 · Aggregated media

FDA lays out plan to close ingredients ‘loophole’ targeted by RFK Jr

Food DiveOriginal source

🌍Aug 10discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends Blinkit's Malad store licence; conducts raids in Mumbai and parts of Maharashtra

Mid-DayOriginal source

🌍Aug 10discoverynews.google.comTier 3 · Aggregated media

This Psychedelic Biotech Play Could See a Leg Up After Encouraging LSD Trials

TheStreet ProOriginal source

🇺🇸Aug 10Industryyprime.comTier 1 · Company source

YPrime Named to Everest Group Top 50™ Pharmaceutical Technology Providers, Reinforcing Clinical Trial Technology Leadership

YPrimeOriginal source